Skip to content
BioView logo — BioView improves cancer patients assessments and outcomes by...

BioView

BioView improves cancer patients assessments and outcomes by providing novel automated imaging and analysis solutions

Founded 2000 United States Billerica, United States 37 employees Biotechnology, Health Care

General Information

Company Name BioView
Founded Year 2000
Location United States Billerica, United States
Employees 37
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with BioView. To contact BioView, visit bioview.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioView compare?

A PDF of BioView and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioView soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioView

BioView is a biotechnology startup that specializes in developing an advanced automated cell diagnostic system tailored for cytogenetics, pathology, and cytological labs. Their groundbreaking Duet™ platform offers automated detection, classification, analysis, and counting of targeted cells for diagnostic and research purposes. With the utilization of bright light illumination for cell morphology and chromosomal analysis, as well as fluorescent illumination for protein and genetic studies, BioView's innovation is at the forefront of precision in cell diagnostics.

Founded in 2000, BioView has positioned itself at the intersection of biotechnology and healthcare, catering to the needs of laboratories in these domains. The company's core strength lies in its fully motorized fluorescent and bright-field microscope, which features a high-resolution camera managed by proprietary imaging, analysis, and review software.

Overall, BioView's groundbreaking technology and innovation have the potential to revolutionize diagnostic processes in laboratories, offering a more efficient and precise approach to cell diagnostics. With the increasing demand for advanced diagnostic solutions, BioView is well-positioned to make a significant impact in the biotechnology and healthcare industries.

Business keywords: Cell Diagnostics, Automated Platform, Cytogenetics, Pathology, Cytological Laboratories, Duet Platform, Automated Detection, Classification, Cell Analysis, Bright Light Illumination, Fluorescent Illumination, Microscopic Imaging, Chromosomal Analysis, Genetic Studies

No funding data available for BioView yet.

BioView Alternatives & Competitors

BioView vs

Advanced imaging and computational analysis for karyotyping, H&E, IHC and FISH testing and conclusiv...

81 employees
Biotechnology, Health Care

FAQ About BioView

BioView improves cancer patients assessments and outcomes by providing novel automated imaging and analysis solutions
BioView was founded in 2000.
BioView is headquartered in Billerica, United States.
BioView operates in Biotechnology and Health Care. Its work centres on Cell Diagnostics, Automated Platform, Cytogenetics and Pathology.
BioView has approximately 37 employees.
Top alternatives and competitors to BioView include Applied Spectral Imaging (ASI). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioView and Applied Spectral Imaging (ASI) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioView, https://bouncewatch.com/company/bioview-1, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout